Identifying Outcomes Important to Patients with Glomerular Disease and Their Caregivers
Simon Carter(Royal Children's Hospital), Michelle Hladunewich(Sunnybrook Health Science Centre), Liz Lightstone(Imperial College London), Rosanna Coppo(Fondazione Ricerca Molinette), Ana Malvar(Cliniques Universitaires Saint-Luc), M.K.H. Tong, John Boletis(National and Kapodistrian University of Athens), Dawn J. Caster(University of Louisville), Allison Tong(The University of Sydney), Jonathan C. Craig(Flinders University), Yeoungjee Cho, Brad H. Rovin(The Ohio State University Wexner Medical Center), Talia Gutman(The University of Sydney), David W. Johnson(Hennepin County), A. Richard Kitching(Monash Health), Armando Teixeira‐Pinto(The University of Sydney), Samuel Fung(Hong Kong Jockey Club), Angela Yee‐Moon Wang(Texas State University), Karolis Ažukaitis(Vilnius University), Jonathan Barratt(University of Leicester), Jessica Ryan(Monash Medical Centre), Nicole Scholes‐Robertson(The University of Sydney), Jenny I. Shen(Yamaha (Japan)), Richard Lafayette(Stanford Medicine), Arvind Bagga(All India Institute of Medical Sciences), Achilles Hoi Kan Lee(Tuen Mun Hospital), Andrea K. Viecelli(The University of Queensland), Fernando C. Fervenza(Mayo Clinic), Charlotte Logeman(The University of Sydney), Martin Wilkie(Sheffield Teaching Hospitals NHS Foundation Trust), Stephen I. Alexander(University of South Australia), Lorena Ruiz(University of California, Los Angeles), Paul Laboi(York Hospital), Jai Radhakrishnan(Columbia University), Hong Zhang(University of Hawaiʻi at Mānoa), Peter G. Kerr(Monash Health), David C.H. Harris(The University of Sydney), Hernán Trimarchi(Hospital Británico de Buenos Aires), Louese Dunn(National Health Service), D C Cattran(University of Toronto), Jonathan J. Hogan(University of Pennsylvania), Jürgen Floege(RWTH Aachen University), Sean J. Barbour(Provincial Health Services Authority)
Cited by 97
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.7k
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Chronic Kidney Disease and Coronary Artery Disease
|Journal of the American College of Cardiology|2019|716